Quality of Life of Caregivers of Addicts

December 29, 2022 updated by: Saleh Sharkawy, Assiut University

Psychiatric Assessment and Quality of Life of Family Caregivers of Addicts

American Society of Addiction Medicine defined Addiction as a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual's life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences.

Addiction is considered as a "family disease." Addiction affects the individual as well as those around them in terms of occupational and social dysfunction, physical and emotional distress, and financial burden which has a serious impact on the lives of the significant others.

Study Overview

Detailed Description

Addiction is a multifaceted problem- it negatively alters the quality of life of not only addicts but also the family members who live with them. Caregiving to an individual suffering from addiction is physically, mentally, socially and emotionally challenging. These caregivers are most burdened as the assistance they provide is multidimensional.

The Quality of Life Group of the World Health Organization (WHO) Division of Mental Health has defined QOL as "an individual's perception of their position in life in the context of the culture and value system in which they live and in relation to their goals, expectations, standards, and concerns " .

Family members are not all equally affected and they suffer in different degrees based on their closeness to the addict and distance from the addict's behavior. Most of the time, a member of the family assumes the role of caregiver, and he or she is most burdened from this process.

The Family Caregiver Alliance (2014) defines family (or informal) caregivers as "any relative, partner, friend, or neighbor who has a significant personal relationship with, and provides a broad range of assistance for, an older person or an adult with a chronic or disabling condition" .

Researchers have described addiction as one of the significant causes of family destruction and disturbed relationship.Family relationships are at risk owing to addiction and associated hazards. Researches addressing the health issues of families have reported numerous mental health problems among children and spouses of addicts. A study has depicted children of addict fathers experiencing depression, anxiety and hypomania. Children of addicts also suffered from different internalised and externalised problem in men.

However, published studies on family caregivers of addicts are limited. This study aimed to evaluate QOL and psychiatric symptoms in family caregivers of addicts.

Study Type

Observational

Enrollment (Anticipated)

160

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Assiut, Egypt, 71515
        • Assiut University
        • Contact:
          • Vice president of graduate studies Of Assiut University
          • Phone Number: +2088 22080150
          • Email: vp_grad@aun.edu.eg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Family caregivers of addicts who come to an addiction clinic and unit of neuropsychiatry hospital of assiut university hospital

Description

Inclusion Criteria:

  • As defined by The Family Caregiver Alliance (2014) "any relative, partner, friend, or neighbor who has a significant personal relationship with, and provides a broad range of assistance for, an older person or an adult with a chronic or disabling condition" .
  • aged ≥18 years old.
  • being a family caregiver for more than three months (considered the minimum time for the caregivers to be able to feel the effects of care).
  • living or residing near the drug-dependent.

Exclusion Criteria:

  • who stopped living in the city
  • the presence of previous psychiatric illness and caregiver who was also addicts. • Refuse to participate in the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
quality of life evaluation
Time Frame: 2 weeks
evaluation of quality of life by WHO-QOL-BREFF scale
2 weeks
psychiatric symptoms
Time Frame: 12-15 minutes
evaluation of psychiatric symptoms by Symptom Checklist-90-Revised (SCL-90-R)
12-15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Saleh Ahmed Mahmoud, Resident, Assiut University
  • Study Chair: ALaa EL-DIN Mohamed darweesh, MD, Assiut University
  • Study Director: Mohamed Fawzy Mohamed, AP, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2023

Primary Completion (Anticipated)

August 1, 2023

Study Completion (Anticipated)

October 1, 2023

Study Registration Dates

First Submitted

October 10, 2021

First Submitted That Met QC Criteria

October 10, 2021

First Posted (Actual)

October 22, 2021

Study Record Updates

Last Update Posted (Actual)

January 3, 2023

Last Update Submitted That Met QC Criteria

December 29, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • qolfc

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Addiction

Clinical Trials on 1-WHOQOL-BREF(WHO-Quality of life-BREFF) Arabic version Scale

3
Subscribe